University of South Florida Infectious Disease Division Commits to Safety with Textile Technology
As an innovator in infectious disease prevention and patient safety, the University of South Florida College of Medicine's Division of Infectious Disease and International Medicine is instituting high-tech, fluid repellant Vestex lab coats for its physicians and advanced clinical staff. Engineered as a first line of defense against blood and other bodily fluids, Vestex will help prevent contamination of clothing in healthcare textiles.
"We are committed to excellence in healthcare and that begins with safety for our patients and our employees," says John Sinnott, MD, FACP, FISDA, associate dean and division director. "As the latest advance in textile technology, Vestex will be another instrument in our quest for innovation. This is the next step in our mission to be an internationally outstanding academic center and resource for infectious disease identification, prevention and treatment issues."
As the principal infectious disease organization in Florida, the division conducts research, analyzes infectious disease policies, and provides clinical care and training to healthcare workers both locally and throughout the world. Sinnott is a Fellow of the American College of Physicians and the Infectious Disease Society of America.
Developed by Orlando-based Vestagen Technical Textiles, Vestex uses exclusively licensed and patented technology to repel blood and bodily fluids, wick away perspiration, guard against degradation from microorganisms, and control odors. The innovative, nanotechnology-based textile helps prevent contamination of the clothing while keeping the wearer clean, cool and dry.
"Frequent exposure of healthcare workers to contaminants is predictable in high patient-contact areas like infectious disease units," said Ben Favret, president and CEO of Vestagen. "Vestex will help keep physicians safe from unpredictable spills or splatters that may occur and introduce a new level of protection."
To learn more about Vestex technology, visit www.vestexprotects.com.
Ensuring Safety and Comfort: The Urgent Need for Well-Fitted PPE in Health Care
April 5th 2024Personal protective equipment (PPE) stands as the first line of defense against infectious diseases in health care. Yet, the issue of ill-fitting PPE, especially for women, remains a significant challenge.
COVID-19 Harmonization: Balancing Risks and Benefits of CDC's Latest Move
March 11th 2024The CDC's recent decision to align recommendations for respiratory viruses, particularly COVID-19, has garnered support from the public and infectious disease societies. However, as the Infectious Diseases Society of America (IDSA) lends its backing to the CDC's harmonization efforts, concerns persist regarding the implications of this shift, especially considering the Omicron variant's unique characteristics and the ongoing challenges posed by COVID-19's multi-system impacts.
Voices of Resilience: Q&A With the Editor of "Corona City: Voices From an Epicenter"
March 1st 2024Step into the diverse and poignant world of "Corona City: Voices From an Epicenter" with editor Lorraine Ash, MA. In this insightful Q&A, learn about the origins of this remarkable anthology, the challenges faced in capturing raw, unfiltered narratives of the COVID-19 pandemic, and the lasting impact of these stories on readers and communities alike.
Rare Disease Day 2024: Spotlight on Rare Infectious Diseases
February 29th 2024Rare Disease Day on February 29, 2024, shines a global light on the impact of rare diseases, including rare infectious diseases. With a focus on early diagnosis and treatment access, this day highlights the struggles of those with rare conditions.
